ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 108 filers reported holding ENZO BIOCHEM INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $127,000 | -89.4% | 15,674 | -86.3% | 0.01% | -89.0% |
Q3 2017 | $1,201,000 | +1.2% | 114,790 | +6.7% | 0.08% | -5.7% |
Q2 2017 | $1,187,000 | +246.1% | 107,576 | -7.6% | 0.09% | +262.5% |
Q1 2015 | $343,000 | -41.3% | 116,370 | -11.6% | 0.02% | -38.5% |
Q4 2014 | $584,000 | -19.2% | 131,646 | -6.2% | 0.04% | -17.0% |
Q3 2014 | $723,000 | -25.9% | 140,413 | -24.5% | 0.05% | -27.7% |
Q2 2014 | $976,000 | – | 186,003 | – | 0.06% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
HARBERT FUND ADVISORS, INC. | 5,169,337 | $17,420,000 | 25.49% |
Roumell Asset Management, LLC | 1,236,309 | $4,166,000 | 9.86% |
Evermore Global Advisors, LLC | 3,587,251 | $12,089,000 | 2.28% |
CORRADO ADVISORS, LLC | 198,544 | $669,000 | 0.60% |
Fondren Management LP | 175,863 | $593,000 | 0.56% |
MARATHON CAPITAL MANAGEMENT | 247,130 | $832,000 | 0.34% |
KEMPNER CAPITAL MANAGEMENT INC. | 95,476 | $322,000 | 0.21% |
EAM Investors, LLC | 178,939 | $603,000 | 0.15% |
Leap Investments LP | 11,811 | $40,000 | 0.05% |
GSA CAPITAL PARTNERS LLP | 75,900 | $256,000 | 0.03% |